Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2003 2
2004 2
2005 4
2006 1
2007 3
2008 5
2009 3
2010 3
2011 4
2012 5
2013 4
2014 2
2015 1
2016 3
2017 5
2018 6
2019 5
2020 5
2021 6
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Results by year
Filters applied: . Clear all
Page 1
Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis.
Pastushenko I, Mauri F, Song Y, de Cock F, Meeusen B, Swedlund B, Impens F, Van Haver D, Opitz M, Thery M, Bareche Y, Lapouge G, Vermeersch M, Van Eycke YR, Balsat C, Decaestecker C, Sokolow Y, Hassid S, Perez-Bustillo A, Agreda-Moreno B, Rios-Buceta L, Jaen P, Redondo P, Sieira-Gil R, Millan-Cayetano JF, Sanmatrtin O, D'Haene N, Moers V, Rozzi M, Blondeau J, Lemaire S, Scozzaro S, Janssens V, De Troya M, Dubois C, Pérez-Morga D, Salmon I, Sotiriou C, Helmbacher F, Blanpain C. Pastushenko I, et al. Among authors: janssens v. Nature. 2021 Jan;589(7842):448-455. doi: 10.1038/s41586-020-03046-1. Epub 2020 Dec 16. Nature. 2021. PMID: 33328637 Free PMC article.
Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis.
Elgendy M, Cirò M, Hosseini A, Weiszmann J, Mazzarella L, Ferrari E, Cazzoli R, Curigliano G, DeCensi A, Bonanni B, Budillon A, Pelicci PG, Janssens V, Ogris M, Baccarini M, Lanfrancone L, Weckwerth W, Foiani M, Minucci S. Elgendy M, et al. Among authors: janssens v. Cancer Cell. 2019 May 13;35(5):798-815.e5. doi: 10.1016/j.ccell.2019.03.007. Epub 2019 Apr 25. Cancer Cell. 2019. PMID: 31031016 Free article.
The broad phenotypic spectrum of PPP2R1A-related neurodevelopmental disorders correlates with the degree of biochemical dysfunction.
Lenaerts L, Reynhout S, Verbinnen I, Laumonnier F, Toutain A, Bonnet-Brilhault F, Hoorne Y, Joss S, Chassevent AK, Smith-Hicks C, Loeys B, Joset P, Steindl K, Rauch A, Mehta SG, Chung WK, Devriendt K, Holder SE, Jewett T, Baldwin LM, Wilson WG, Towner S, Srivastava S, Johnson HF, Daumer-Haas C, Baethmann M, Ruiz A, Gabau E, Jain V, Varghese V, Al-Beshri A, Fulton S, Wechsberg O, Orenstein N, Prescott K, Childs AM, Faivre L, Moutton S, Sullivan JA, Shashi V, Koudijs SM, Heijligers M, Kivuva E, McTague A, Male A, van Ierland Y, Plecko B, Maystadt I, Hamid R, Hannig VL, Houge G, Janssens V. Lenaerts L, et al. Among authors: janssens v. Genet Med. 2021 Feb;23(2):352-362. doi: 10.1038/s41436-020-00981-2. Epub 2020 Oct 27. Genet Med. 2021. PMID: 33106617 Free PMC article.
Physiologic functions of PP2A: Lessons from genetically modified mice.
Reynhout S, Janssens V. Reynhout S, et al. Among authors: janssens v. Biochim Biophys Acta Mol Cell Res. 2019 Jan;1866(1):31-50. doi: 10.1016/j.bbamcr.2018.07.010. Epub 2018 Jul 18. Biochim Biophys Acta Mol Cell Res. 2019. PMID: 30030003 Free article. Review.
PP2A: the expected tumor suppressor.
Janssens V, Goris J, Van Hoof C. Janssens V, et al. Curr Opin Genet Dev. 2005 Feb;15(1):34-41. doi: 10.1016/j.gde.2004.12.004. Curr Opin Genet Dev. 2005. PMID: 15661531 Review.
In vivo pieces of the PP2A onco-puzzle fallen into place.
Meeusen B, Janssens V. Meeusen B, et al. Among authors: janssens v. Oncoscience. 2017 Dec 20;4(11-12):154-155. doi: 10.18632/oncoscience.384. eCollection 2017 Nov. Oncoscience. 2017. PMID: 29344545 Free PMC article. No abstract available.
The Basic Biology of PP2A in Hematologic Cells and Malignancies.
Haesen D, Sents W, Lemaire K, Hoorne Y, Janssens V. Haesen D, et al. Among authors: janssens v. Front Oncol. 2014 Dec 11;4:347. doi: 10.3389/fonc.2014.00347. eCollection 2014. Front Oncol. 2014. PMID: 25566494 Free PMC article. Review.
58 results